- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
Why Hims & Hers Stock Popped on Monday
March 17, 2025
From Motley Fool
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2025
From Motley Fool
CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
March 14, 2025
From Benzinga
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
March 14, 2025
From Benzinga
From Benzinga
Generate Passive Income From This Low-Cost Vanguard ETF That Is Crushing the S&P 500 in 2025
March 14, 2025
From Motley Fool
Billionaire Ken Griffin More Than Doubled His Stake In This Market-Beating Growth Stock
March 14, 2025
Tickers
LLY
From Motley Fool
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
March 13, 2025
From Benzinga
On Sale Now: 20 Blue Chip Stocks to Buy
March 13, 2025
From Motley Fool
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
March 12, 2025
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 11, 2025
From Benzinga
Merck Injects $1 Billion To Expand Vaccine Production In US
March 11, 2025
From Benzinga
Why Hims & Hers Health Stock Just Popped
March 11, 2025
From Motley Fool
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss
March 11, 2025
From Benzinga
From Motley Fool
Is Eli Lilly Stock a Buy?
March 11, 2025
From Motley Fool
The Reality of Trump's Tariffs
March 10, 2025
From Motley Fool
The State of Weight Loss Drugs
March 10, 2025
From Motley Fool
From Benzinga
3 Cold Stocks That Can Bounce Back This Week
March 10, 2025
From Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 08, 2025
From Motley Fool
Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
March 07, 2025
From Benzinga
From Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
March 06, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.